Nanoparticle-based scaffolds and implants, methods for making the same, and applications thereof
Implant-associated bacterial infections are one of the most serious complications in orthopedic surgery. Treatment of these infections often requires multiple operations, device removal, long-term systemic antibiotics, and extended rehabilitation, and is frequently ineffective, leading to worse clinical outcomes and increased financial costs. Silver nanoparticle/poly(DL-lactic-co-glycolic acid) (PLGA)-coated stainless steel alloy (SNPSA) was evaluated as a potential antimicrobial implant material. It was found that SNPSA exhibited strong antibacterial activity in vitro and ex vivo, and promoted MC3T3-E1 pre-osteoblasts proliferation and maturation in vitro. Furthermore, SNPSA implants induced osteogenesis while suppressing bacterial survival in contaminated rat femoral canals. The results indicate that SNPSA has simultaneous antimicrobial and osteoinductive properties that make it a promising therapeutic material in orthopedic surgery.
1. An implantable device, comprising:
a plurality of silver nanoparticles as an antimicrobial agent dispersed in a polymeric material forming an antimicrobial polymeric coating on at least a portion of a surface of the implantable device and a bioactive agent for bone formation,
wherein the polymeric material comprises nucleophilic moieties having nucleophilic characteristics that stabilize the silver nanoparticles and the silver nanoparticles constitute about 0.1%-2% or 5% by weight of the polymeric material,
wherein the bioactive agent is a protein agent selected from the group consisting of bone morphogenetic protein (BMP), transforming growth factor (TGF) beta-1 TGF-beta-2, TGF-beta-3, BMP-2, BMP-3, BMP-7, and insulin-like growth factor (IGF)-1,
wherein the implantable device is configured such that when it is placed in an osteogenic medium for incubation, surface free energy of the silver nanoparticles on the implantable device, which comprises a non-dispersion component, a dispersion component, and a polar component, increases along with the non-dispersion component, and
wherein the non-dispersion component imparts higher bioactivity and total protein adsorption to the polymeric material such that adsorption of the protein agent on the surface is positively correlated with the non-dispersion component of surface free energy, which increases along with percentage of the silver nanoparticles and incubation time in the osteogenic medium.
2. The implantable device of claim 1 , wherein the silver nanoparticles are deposited on a portion of a surface of the implantable device.
3. The implantable device of claim 1 , wherein the implantable device is selected from the group consisting of an implantable intervertebral device, a cervical fusion device, a scaffold, a fixture, a dental implant, a dental disc, a dental bridge, a retainer clip, a dental screw, a dental housing, a dental bone graft, a dental crown, an orthopedic implant, an intramedullary rod, a temporary pin, a permanent pin, a bone plate, a bone screw, and a combination thereof.
4. The implantable device of claim 1 , wherein the polymeric material is selected from the group consisting of a biocompatible polymer, a biodegradable polymer, a bioabsorbable polymer, and a combination thereof.
5. The implantable device of claim 1 , wherein the silver nanoparticles constitute about 5% by weight of the polymeric material.
6. The implantable device of claim 1 , wherein the silver nanoparticles constitute about 2% by weight of the polymeric material.
7. The implantable device of claim 1 , wherein the silver nanoparticles have a mean size of 100 nm or smaller.
8. The implantable device of claim 1 , wherein the silver nanoparticles have a mean size of 80 nm or smaller.
9. The implantable device of claim 1 , wherein the silver nanoparticles have a mean size of 50 nm or smaller.
10. The implantable device of claim 1 , wherein the silver nanoparticles have a mean size of 40 nm or smaller.
11. The implantable device of claim 1 , wherein the silver nanoparticles have a mean size of between 20 nm and 40 nm.
12. The implantable device of claim 1 , wherein the silver nanoparticles have a mean size of 30 nm or smaller.
13. The implantable device of claim 1 , further comprising an additional polymeric coating deposited over the antimicrobial polymeric coating that comprises the silver nanoparticles.
14. The implantable device of claim 2 , wherein the bioactive agent is BMP-2.
15. The implantable device of claim 13 , wherein the bioactive agent is further included in the additional polymeric coating.
16. The implantable device of claim 15 , wherein the bioactive agent is BMP-2.
17. A method of fabricating an implantable device according to claim 1 , comprising incorporating a plurality of silver nanoparticles as an antimicrobial agent dispersed in a polymeric material comprising nucleophilic moieties having nucleophilic characteristics that stabilize the silver nanoparticles, wherein the antimicrobial agent is deposited discontinuously over a contact surface of the device.
18. The method of claim 17 , comprising: forming a coating of the polymeric material on the implantable device, and subsequently depositing the antimicrobial agent to the implantable device.
19. The method of claim 17 , comprising: forming a mixture comprising the antimicrobial agent and the polymeric material, depositing the mixture on the implantable device to form a coating.
20. The method of claim 17 , comprising: dispersing the antimicrobial agent in the polymeric material to form a mixture, and using the mixture to form a portion of the implantable device or the entire implantable device.
21. The implantable device according to claim 1 , wherein the surface comprises an apatite where the surface is modified with the apatite.